(Q37960371)

26 August 2017

title

Angiotensin-converting enzyme 2: enhancing the degradation of angiotensin II as a potential therapy for diabetic nephropathy (English)

1 reference

26 August 2017

1

Daniel Batlle

1 reference

26 August 2017

Jan Wysocki

2

1 reference

26 August 2017

Maria J Soler

series ordinal

3

1 reference

26 August 2017

Keerthi Ranganath

series ordinal

4

1 reference

26 August 2017

language of work or name

English

0 references

publication date

23 November 2011

1 reference

26 August 2017

1 reference

26 August 2017

volume

81

1 reference

26 August 2017

issue

6

1 reference

26 August 2017

page(s)

520-528

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.2011.381

26 August 2017

exact match

0 references

cites work

A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

Identification and characterisation of the angiotensin converting enzyme-3 (ACE3) gene: a novel mammalian homologue of ACE.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

Collectrin, a collecting duct-specific transmembrane glycoprotein, is a novel homolog of ACE2 and is developmentally regulated in embryonic kidneys

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

Angiotensin-converting enzyme-2 (ACE2): comparative modeling of the active site, specificity requirements, and chloride dependence

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

Angiotensin-converting enzyme-2: a molecular and cellular perspective

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

The importance of the intrarenal renin-angiotensin system

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

Direct renin inhibition and the kidney

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

Decreased cardiac Ang-(1-7) is associated with salt-induced cardiac remodeling and dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

Increased ACE 2 and decreased ACE protein in renal tubules from diabetic mice: a renoprotective combination?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

ACE and ACE2 activity in diabetic mice.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

Localization of ACE2 in the renal vasculature: amplification by angiotensin II type 1 receptor blockade using telmisartan

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

Angiotensin-converting enzyme 2 is an essential regulator of heart function

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

Angiotensin metabolism in renal proximal tubules, urine, and serum of sheep: evidence for ACE2-dependent processing of angiotensin II

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

Impairment of the angiotensin-converting enzyme 2-angiotensin-(1-7)-Mas axis contributes to the acceleration of two-kidney, one-clip Goldblatt hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

Mas deficiency in FVB/N mice produces marked changes in lipid and glycemic metabolism

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

Genetic deletion of the angiotensin-(1-7) receptor Mas leads to glomerular hyperfiltration and microalbuminuria.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

Effect of ACE2 and angiotensin-(1-7) in a mouse model of early chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

Angiotensin-converting enzyme 2 autoantibodies: further evidence for a role of the renin-angiotensin system in inflammation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

The role of angiotensin converting enzyme 2 in the generation of angiotensin 1-7 by rat proximal tubules

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

Membrane-associated zinc peptidase families: comparing ACE and ACE2.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

Intrarenal renin angiotensin system revisited: role of megalin-dependent endocytosis along the proximal nephron

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

Renal ACE2 expression in human kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

Expression of ACE and ACE2 in individuals with diabetic kidney disease and healthy controls

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

The emerging role of ACE2 in physiology and disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

Influence of genetic background on albuminuria and kidney injury in Ins2(+/C96Y) (Akita) mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

ACE2 deficiency modifies renoprotection afforded by ACE inhibition in experimental diabetes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

Renal ACE and ACE2 expression in early diabetic rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

Glomerular renin angiotensin system in streptozotocin diabetic and Zucker diabetic fatty rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

Polymorphisms in the gene encoding angiotensin I converting enzyme 2 and diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

Investigation of ACE, ACE2 and AGTR1 genes for association with nephropathy in Type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

NF-kappaB-dependent increase in intrarenal angiotensin II induced by proteinuria

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

Tissue gene expression of renin-angiotensin system in human type 2 diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

New aspects of the renin-angiotensin system: angiotensin-converting enzyme 2 - a potential target for treatment of hypertension and diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

Genetic Ace2 deficiency accentuates vascular inflammation and atherosclerosis in the ApoE knockout mouse.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

Vascular angiotensin-converting enzyme 2: lord of the ring?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

Human recombinant ACE2 reduces the progression of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

Angiotensin-converting enzyme (ACE) 2 overexpression ameliorates glomerular injury in a rat model of diabetic nephropathy: a comparison with ACE inhibition

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

Structure-based identification of small-molecule angiotensin-converting enzyme 2 activators as novel antihypertensive agents.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

Urinary mRNA expression of ACE and ACE2 in human type 2 diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.381

7 January 2021

Identifiers

DOI

10.1038/KI.2011.381

1 reference

26 August 2017

1 reference